642 related articles for article (PubMed ID: 21336307)
1. p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs.
Chang CJ; Chao CH; Xia W; Yang JY; Xiong Y; Li CW; Yu WH; Rehman SK; Hsu JL; Lee HH; Liu M; Chen CT; Yu D; Hung MC
Nat Cell Biol; 2011 Mar; 13(3):317-23. PubMed ID: 21336307
[TBL] [Abstract][Full Text] [Related]
2. Mutant p53 Attenuates Oxidative Phosphorylation and Facilitates Cancer Stemness through Downregulating miR-200c-PCK2 Axis in Basal-Like Breast Cancer.
Chao CH; Wang CY; Wang CH; Chen TW; Hsu HY; Huang HW; Li CW; Mai RT
Mol Cancer Res; 2021 Nov; 19(11):1900-1916. PubMed ID: 34312289
[TBL] [Abstract][Full Text] [Related]
3. Wild-type p53 suppresses the epithelial-mesenchymal transition and stemness in PC-3 prostate cancer cells by modulating miR‑145.
Ren D; Wang M; Guo W; Zhao X; Tu X; Huang S; Zou X; Peng X
Int J Oncol; 2013 Apr; 42(4):1473-81. PubMed ID: 23404342
[TBL] [Abstract][Full Text] [Related]
4. Core 3 mucin-type O-glycan restoration in colorectal cancer cells promotes MUC1/p53/miR-200c-dependent epithelial identity.
Ye J; Wei X; Shang Y; Pan Q; Yang M; Tian Y; He Y; Peng Z; Chen L; Chen W; Wang R
Oncogene; 2017 Nov; 36(46):6391-6407. PubMed ID: 28745318
[TBL] [Abstract][Full Text] [Related]
5. p53 Spreads out further: suppression of EMT and stemness by activating miR-200c expression.
Schubert J; Brabletz T
Cell Res; 2011 May; 21(5):705-7. PubMed ID: 21483453
[No Abstract] [Full Text] [Related]
6. Transcriptional repression of miR-200 family members by Nanog in colon cancer cells induces epithelial-mesenchymal transition (EMT).
Pan Q; Meng L; Ye J; Wei X; Shang Y; Tian Y; He Y; Peng Z; Chen L; Chen W; Bian X; Wang R
Cancer Lett; 2017 Apr; 392():26-38. PubMed ID: 28163188
[TBL] [Abstract][Full Text] [Related]
7. Antcin-A Modulates Epithelial-to-Mesenchymal Transition and Inhibits Migratory and Invasive Potentials of Human Breast Cancer Cells via p53-Mediated miR-200c Activation.
Kumar KJS; Vani MG; Hsieh HW; Lin CC; Wang SY
Planta Med; 2019 Jul; 85(9-10):755-765. PubMed ID: 31185503
[TBL] [Abstract][Full Text] [Related]
8. miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance.
Mutlu M; Raza U; Saatci Ö; Eyüpoğlu E; Yurdusev E; Şahin Ö
J Mol Med (Berl); 2016 Jun; 94(6):629-44. PubMed ID: 27094812
[TBL] [Abstract][Full Text] [Related]
9. Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential.
Knezevic J; Pfefferle AD; Petrovic I; Greene SB; Perou CM; Rosen JM
Oncogene; 2015 Dec; 34(49):5997-6006. PubMed ID: 25746005
[TBL] [Abstract][Full Text] [Related]
10. Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs.
Guttilla IK; Phoenix KN; Hong X; Tirnauer JS; Claffey KP; White BA
Breast Cancer Res Treat; 2012 Feb; 132(1):75-85. PubMed ID: 21553120
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-200c inhibits epithelial-mesenchymal transition, invasion, and migration of lung cancer by targeting HMGB1.
Liu PL; Liu WL; Chang JM; Chen YH; Liu YP; Kuo HF; Hsieh CC; Ding YS; Chen WW; Chong IW
PLoS One; 2017; 12(7):e0180844. PubMed ID: 28727734
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer.
Gwak JM; Kim HJ; Kim EJ; Chung YR; Yun S; Seo AN; Lee HJ; Park SY
Breast Cancer Res Treat; 2014 Aug; 147(1):39-49. PubMed ID: 25086633
[TBL] [Abstract][Full Text] [Related]
13. Bioluminescence Imaging for Monitoring miR-200c Expression in Breast Cancer Cells and its Effects on Epithelial-Mesenchymal Transition Progress in Living Animals.
Liu J; Shen JX; He D; Zhang GJ
Mol Imaging Biol; 2018 Oct; 20(5):761-770. PubMed ID: 29532351
[TBL] [Abstract][Full Text] [Related]
14. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
[TBL] [Abstract][Full Text] [Related]
15. Chronic treatment of non-small-cell lung cancer cells with gefitinib leads to an epigenetic loss of epithelial properties associated with reductions in microRNA-155 and -200c.
Narita M; Shimura E; Nagasawa A; Aiuchi T; Suda Y; Hamada Y; Ikegami D; Iwasawa C; Arakawa K; Igarashi K; Kuzumaki N; Yoshioka Y; Ochiya T; Takeshima H; Ushijima T; Narita M
PLoS One; 2017; 12(2):e0172115. PubMed ID: 28225782
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-200c-141 and ∆Np63 are required for breast epithelial differentiation and branching morphogenesis.
Hilmarsdóttir B; Briem E; Sigurdsson V; Franzdóttir SR; Ringnér M; Arason AJ; Bergthorsson JT; Magnusson MK; Gudjonsson T
Dev Biol; 2015 Jul; 403(2):150-61. PubMed ID: 25967125
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-200c overexpression plays an inhibitory role in human pancreatic cancer stem cells by regulating epithelial-mesenchymal transition.
Ma C; Ding YC; Yu W; Wang Q; Meng B; Huang T
Minerva Med; 2015 Aug; 106(4):193-202. PubMed ID: 26081037
[TBL] [Abstract][Full Text] [Related]
18. miR-200c, a tumor suppressor that modulate the expression of cancer stem cells markers and epithelial-mesenchymal transition in colorectal cancer.
Karimi Dermani F; Amini R; Saidijam M; Najafi R
J Cell Biochem; 2018 Jul; 119(7):6288-6295. PubMed ID: 29663476
[TBL] [Abstract][Full Text] [Related]
19. miR-200c-3p Regulates Epitelial-to-Mesenchymal Transition in Epicardial Mesothelial Cells by Targeting Epicardial Follistatin-Related Protein 1.
Pontemezzo E; Foglio E; Vernucci E; Magenta A; D'Agostino M; Sileno S; Astanina E; Bussolino F; Pellegrini L; Germani A; Russo MA; Limana F
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34067060
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol Inhibits Proliferation, Invasion, and Epithelial-Mesenchymal Transition by Increasing miR-200c Expression in HCT-116 Colorectal Cancer Cells.
Karimi Dermani F; Saidijam M; Amini R; Mahdavinezhad A; Heydari K; Najafi R
J Cell Biochem; 2017 Jun; 118(6):1547-1555. PubMed ID: 27918105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
